| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S81873-5mg促销 |
98.00% | ￥170.00 ￥136.00 |
6 | - | - | - | - |
|
S81873-10mg促销 |
98.00% | ￥298.00 ￥238.00 |
6 | - | - | - | - |
|
S81873-25mg促销 |
98.00% | ￥590.00 ￥472.00 |
6 | - | - | - | - |
|
S81873-50mg促销 |
≥98% | ￥1090.00 ￥872.00 |
货期：2-3天 | - | - | - | - |
|
S81873-100mg促销 |
≥98% | ￥2130.00 ￥1700.00 |
货期：2-3天 | - | - | - | - |
|
S81873-200mg |
≥98% | ￥2970.00 |
货期：2-3天 | - | - | - | - |
|
| 产品描述： | Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | CCK-1 receptor;cholecystokinin | ||||||||||||||||||||
| 体内研究： | The effects of pancreatic rest by oral administration of CCK-1 receptor antagonist Loxiglumide and pancreas stimulation are investigated via endogenous CCK release induced by po protease inhibitor camostat on the recovery of pancreatic secretory function, and biochemical and histological changes of the pancreas after acute hemorrhagic pancreatitis. Oral administration of CCK-1 receptor antagonist Loxiglumide with a dose of 50 mg/kg body weight inhibits pancreatic exocrine secretion for more than 12 h. Thus, every 12-h administration of Loxiglumide might have completely blocks the effect of endogenously released CCK on the pancreas (pancreatic rest) | ||||||||||||||||||||
| 参考文献： | 1. Jia D, et al. Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats. World J Gastroenterol. 2015 Jul 7;21(25):7742-53. | ||||||||||||||||||||
| 溶解性： | DMSO : ≥ 100 mg/mL (216.74 mM) | ||||||||||||||||||||
| 保存条件： | 2-8℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
